Clinical Deterioration in Cerebral Venous Thrombosis: A Predictive Study
Risk Factor Analysis and Development of a Predictive Model for Clinical Deterioration During Hospitalization in Patients With Cerebral Venous Thrombosis
1 other identifier
observational
273
1 country
1
Brief Summary
The objective of this retrospective, prospective, multicenter cohort study is to determine the risk factors for deterioration of CVT patients after admission and establish a scoring model for risk stratification of patients. This study included two stages, the first stage was to enroll CVT patients from a single center from 2017 to 2022 for modeling, and the second stage was to enroll CVT patients from three centers in 2023 for external validation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
January 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 20, 2024
CompletedFebruary 20, 2024
February 1, 2024
12 months
January 5, 2024
February 16, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Number of Participants with CVT deteriorated on radiology
One of the following situations occurs: new or progressive bleeding or infarction, midline displacement (\>3mm), increased cerebral edema, and placeholder effect by comparing the CT before and after; mRS and/or GCS decreased due to decreased consciousness, increased focal neurological impairment, new focal neurological impairment or death.
After admission until discharge, a maximum of 30 days
Number of Participants with altered neurological function
mRS Score decreased due to decreased consciousness, increased focal neurological impairment, new focal neurological impairment or death.
After admission until discharge, a maximum of 30 days
Number of Participants with altered consciousness
GCS Score decreased
After admission until discharge, a maximum of 30 days
Secondary Outcomes (2)
Neurological function at 30th day after onset (mRS)
30th day after onset
Emergency surgery rates
After admission until discharge, a maximum of 30 days
Eligibility Criteria
Patients with cerebral venous thrombosis (CVT)
You may qualify if:
- Age≥ 18 years old
- Patients were diagnosed with cerebral venous thrombosis (CVT) through imaging techniques such as Computed Tomography Venography (CTV), Magnetic Resonance Venography (MRV), or Digital Subtraction Angiography (DSA)
- The diagnostic algorithm for CVT conformed to the current guideline criteria
You may not qualify if:
- Patients who had performed endovascular treatment (EVT) or decompressive craniectomy (DC) before admission and those whose primary treatment was EVT or DC rather than conservative treatment after admission
- Patients with severe hepatic or renal insufficiency
- Patients with intracranial tumors
- Patients with other cerebrovascular diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Tiantan Hospitallead
- Beijing Chao Yang Hospitalcollaborator
- Beijing Friendship Hospitalcollaborator
Study Sites (1)
Capital Medical University Affiliated Beijing Tiantan Hospital
Beijing, Beijing Municipality, China
Related Publications (1)
Feng Y, Mo S, Li X, Jiang P, Wu J, Li J, Liu P, Wang S, Liu Q, Tong X. Development and validation of a score for clinical deterioration in patients with cerebral venous thrombosis. Neurosurg Rev. 2025 Jan 16;48(1):56. doi: 10.1007/s10143-025-03224-7.
PMID: 39815140DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Department of cerebrovascular Neurosurgery
Study Record Dates
First Submitted
January 5, 2024
First Posted
February 20, 2024
Study Start
January 1, 2023
Primary Completion
December 31, 2023
Study Completion
January 1, 2024
Last Updated
February 20, 2024
Record last verified: 2024-02